Phase I Trial of [(99m)Tc]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors

SIMPLE SUMMARY: Prostate and breast cancers are the most common malignancies. Accurate diagnosis and staging of diseases are important for the prognosis and determination of treatment tactics. The gastrin-releasing peptide receptor is overexpressed in over 80% of estrogen receptor-positive breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chernov, Vladimir, Rybina, Anastasiya, Zelchan, Roman, Medvedeva, Anna, Bragina, Olga, Lushnikova, Nadejda, Doroshenko, Artem, Usynin, Evgeniy, Tashireva, Liubov, Vtorushin, Sergey, Abouzayed, Ayman, Rinne, Sara S., Sörensen, Jens, Tolmachev, Vladimir, Orlova, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046460/
https://www.ncbi.nlm.nih.gov/pubmed/36980517
http://dx.doi.org/10.3390/cancers15061631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046460/
https://www.ncbi.nlm.nih.gov/pubmed/36980517
http://dx.doi.org/10.3390/cancers15061631

Ejemplares similares